Pfizer to Seek U.S. Authorization For COVID-19 Booster Shot



Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant. Awesome!


Read more about it


Photo Credit: Martin Sanchez

15 views0 comments